Vergoeding 2019-2023 voor ATC-subgroep L02AE : Gonadoreline-analogen
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| L02AE01 Busereline (Suprefact ®) | 903.890 | 874.830 | 618.820 | 764.100 | 545.190 |
| L02AE02 Leuproreline (Lucrin pds ®) | 15.829.700 | 15.533.600 | 12.108.100 | 11.742.000 | 11.806.900 |
| L02AE03 Gosereline (Zoladex ®) | 13.141.800 | 13.356.500 | 12.678.500 | 13.262.900 | 13.504.100 |
| L02AE04 Triptoreline (Pamorelin ®) | 3.692.500 | 4.296.100 | 5.109.100 | 6.079.100 | 7.119.100 |
| Totaal | 33.567.890 | 34.061.030 | 30.514.520 | 31.848.100 | 32.975.290 |